Catalyst Wire Dossier Catalyst Wire Dossier

reconvalescent plasma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for reconvalescent plasma, covering 2022-02-10 to 2022-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals [Phase 2]

See pricing